Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin sensitivity in peripheral tissues refers to the ability of cells—primarily skeletal muscle, adipose (fat) tissue, and liver—to respond to the hormone insulin by absorbing glucose from the bloodstream and carrying out metabolic processes such as glycogen synthesis, lipid storage, and suppression of gluconeogenesis. High insulin sensitivity means these tissues efficiently respond to normal levels of insulin; low sensitivity (insulin resistance) means a diminished response requiring higher insulin concentrations for the same effect. It is a key factor in glucose homeostasis and is impaired in type 2 diabetes and metabolic syndrome.
Enhancement of insulin signaling pathways in peripheral tissues (muscle, adipose tissue, liver) leading to increased glucose uptake and utilization.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Sensitivity (Peripheral Tissues).